GlassScriptPhysician profile
Debra Ann Kosko
NPI 1447431424
$2,363.64
in general payments reported to CMS, 2019-2025
5 companies · $78.83 in 2025
The $78.83 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $230 · 2024: $2,055 · 2025: $78.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,044 · Consulting Fee: $880 · Food and Beverage: $210.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,044.21 |
| Consulting Fee | $880.00 |
| Food and Beverage | $209.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,055.10 | 2024 | |
| Sanofi Pasteur INC. | $110.00 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.96 | 2022 | |
| Viiv Healthcare Company | $78.83 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $21.75 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debra Kosko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.